Effect of antiplatelet/anticoagulant therapy on severe ischemic complications in patients with giant cell arteritis: A cumulative meta-analysis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Martínez-Taboada, 2000, Arteritis de células gigantes, Seminarios de Reumatología, 1, 141
Aiello, 1993, Visual prognosis in giant cell arteritis, Ophthalmology, 100, 550, 10.1016/S0161-6420(93)31608-8
Hayreh, 2003, Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy, Ophthalmology, 110, 1204, 10.1016/S0161-6420(03)00228-8
Liozon, 2001, Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients, Am J Med, 111, 211, 10.1016/S0002-9343(01)00770-7
Cid, 1998, Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis, Arthritis Rheum, 41, 26, 10.1002/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0
González-Gay, 1998, Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment, Arthritis Rheum, 41, 1497, 10.1002/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z
Salvarani, 2009, Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis, Rheumatology (Oxford), 48, 250, 10.1093/rheumatology/ken465
Berger, 2009, High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition, Rheumatology (Oxford), 48, 258, 10.1093/rheumatology/ken480
Nesher, 2004, Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis, Arthritis Rheum, 50, 1332, 10.1002/art.20171
Lee, 2006, Antiplatelet and anticoagulant therapy in patients with giant cell arteritis, Arthritis Rheum, 54, 3306, 10.1002/art.22141
Hellmann, 2004, Low-dose aspirin in the treatment of giant cell arteritis, Arthritis Rheum, 50, 1026, 10.1002/art.20172
Mukhtyar, 2009, EULAR recommendations for the management of large vessel vasculitis, Ann Rheum Dis, 68, 318, 10.1136/ard.2008.088351
Gonzalez-Gay, 2004, Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis, Medicine (Baltimore), 83, 342, 10.1097/01.md.0000145369.25558.b5
Narváez, 2008, Impact of antiplatelet therapy in the development of severe ischemic complications and in the outcome of patients with giant cell arteritis, Clin Exp Rheumatol, 26, S57
Stroup, 2000, Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group, JAMA, 283, 2008, 10.1001/jama.283.15.2008
Moher, 2009, The PRISMA group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Med, 6, e1000097, 10.1371/journal.pmed.1000097
Wells
Vandenbroucke, 2007, Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration, Ann Intern Med, 147, W163, 10.7326/0003-4819-147-8-200710160-00010-w1
2011, GRADE handbook for grading quality of evidence and strength of recommendation. version 3.6
Guyatt, 2008, Rating quality of evidence and strength of recommendations GRADE: an emerging consensus on rating quality of evidence and strength of recommendations, BMJ, 336, 924, 10.1136/bmj.39489.470347.AD
DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2
Sterne, 2011, Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials, BMJ, 343, d4002, 10.1136/bmj.d4002
Borenstein, 2009, Publication bias, 277
Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629
Lau, 1995, Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care, J Clin Epidemiol, 48, 45, 10.1016/0895-4356(94)00106-Z
Borenstein, 2005
Armona, 1995, Giant cell arteritis. A study of 191 patients, Med Clin (Barc), 105, 734
Brack, 1999, Disease pattern in cranial and large-vessel giant cell arteritis, Arthritis Rheum, 42, 311, 10.1002/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F
Huston, 1978, Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study, Ann Intern Med, 88, 162, 10.7326/0003-4819-88-2-162
Duhaut, 1999, Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease. Groupe de Recherche sur l'Artérite à Cellules Géantes, Ann Rheum Dis, 58, 335, 10.1136/ard.58.6.335
Myklebust, 1996, A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis, Br J Rheumatol, 35, 1161, 10.1093/rheumatology/35.11.1161
Franzén, 1992, Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984–1988, J Rheumatol, 19, 273
Weisman, 2002, Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events, Arch Intern Med, 162, 2197, 10.1001/archinte.162.19.2197
Caspi, 2000, The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients, Arthritis Rheum, 43, 103, 10.1002/1529-0131(200001)43:1<103::AID-ANR13>3.0.CO;2-C
Segal, 2003, Early and late effects of low-dose aspirin on renal function in elderly patients, Am J Med, 115, 462, 10.1016/S0002-9343(03)00436-4
Lau, 1992, Cumulative meta-analysis of therapeutic trials for myocardial infarction, N Engl J Med, 327, 248, 10.1056/NEJM199207233270406
Martinez-Taboada, 2003, Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy, Rheumatology (Oxford), 42, 1055, 10.1093/rheumatology/keg293
Machado, 1989, A population-based case–control study of temporal arteritis: evidence for an association between temporal arteritis and degenerative vascular disease?, Int J Epidemiol, 18, 836, 10.1093/ije/18.4.836
Duhaut, 1998, Giant cell arteritis and cardiovascular risk factors: a multicenter, prospective case–control study. Groupe de Recherche sur l'Artérite à Cellules Géantes, Arthritis Rheum, 41, 1960, 10.1002/1529-0131(199811)41:11<1960::AID-ART10>3.0.CO;2-X
Uddhammar, 2002, Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden, J Rheumatol, 29, 737
Spiera, 2006, Therapy for giant cell arteritis: can we do better?, Arthritis Rheum, 54, 3071, 10.1002/art.22142
de Souza, 2010, Antiplatelet therapy for the prevention of arterial ischemic events in Takayasu arteritis, Circ J, 74, 1236, 10.1253/circj.CJ-09-0905